Harnal and hepatic neoplasm malignant 
Harnal and hepatic neoplasm malignant Patient Reports February 13, 2012
Harnal Side Effects Report #5924274-0
Harnal side effect was reported by a Physician from on Oct 15, 2008. Male patient, weighting 132.7 lb, was diagnosed with benign prostatic hyperplasia, insomnia and was treated with Harnal. After drug was administered, patient experienced the following side effects: ascites, hepatic neoplasm malignant, hepatitis fulminant. Harnal dosage: .2MG. During the same period patient was treated with LENDORMIN D, SOLANAX, TOLEDOMIN, TETRAMIDE, MYSLEE, DEPAS, ZOLOFT, ZEFIX. Patient was hospitalized. Patient died on 03/21/2008.
Harnal Side Effects Report #5947114-2
Harnal side effect was reported by a Physician from on Nov 05, 2008. Male patient, weighting 132.3 lb, was diagnosed with benign prostatic hyperplasia, insomnia and was treated with Harnal. After drug was administered, patient experienced the following side effects: ascites, hepatic neoplasm malignant, hepatitis fulminant. Harnal dosage: .2MG. During the same period patient was treated with LENDORMIN D, SOLANAX, TOLEDOMIN, TETRAMIDE, MYSLEE, DEPAS, ZOLOFT, ZEFIX. Patient was hospitalized. Patient died on 03/21/2008.
Harnal Side Effects Report #6124970-9
Harnal side effect was reported by a Physician from on Mar 17, 2009. Male patient, weighting 132.3 lb, was diagnosed with benign prostatic hyperplasia, insomnia, depression
and was treated with Harnal. After drug was administered, patient experienced the following side effects: ascites, hepatic neoplasm malignant, hepatitis fulminant. Harnal dosage: .2MG. During the same period patient was treated with LENDORMIN D, SOLANAX, TOLEDOMIN, TETRAMIDE, MYSLEE. Patient was hospitalized. Patient died on 03/21/2008.Harnal Side Effects Report #6135821-0
Harnal side effect was reported by a Physician from on Mar 24, 2009. Male patient, weighting 132.3 lb, was diagnosed with benign prostatic hyperplasia, insomnia, depression
and was treated with Harnal. After drug was administered, patient experienced the following side effects: ascites, hepatic neoplasm malignant, hepatitis fulminant. Harnal dosage: .2MG. During the same period patient was treated with LENDORMIN D, SOLANAX, TOLEDOMIN, TETRAMIDE, MYSLEE. Patient was hospitalized. Patient died on 03/21/2008.